These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11034262)

  • 1. Single dose pharmacokinetics of syrup of ipecac.
    Scharman EJ; Hutzler JM; Rosencrance JG; Tracy TS
    Ther Drug Monit; 2000 Oct; 22(5):566-73. PubMed ID: 11034262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
    Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.
    Asano T; Watanabe J; Sadakane C; Ishihara K; Hirakura K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Fujii Y; Yamashita M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):29-35. PubMed ID: 11996324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of ipecac alkaloids in human volunteers.
    Yamashita M; Yamashita M; Azuma J
    Vet Hum Toxicol; 2002 Oct; 44(5):257-9. PubMed ID: 12361104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine.
    Asano T; Sadakane C; Ishihara K; Yanagisawa T; Kimura M; Kamei H
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):197-206. PubMed ID: 11417863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of ipecac alkaloids in emergency patients.
    Moran DM; Crouch DJ; Finkle BS
    Ann Emerg Med; 1984 Dec; 13(12):1100-2. PubMed ID: 6150666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
    Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
    Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities.
    Asano T; Kushida H; Sadakane C; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T
    Biol Pharm Bull; 2001 Jun; 24(6):678-82. PubMed ID: 11411558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets.
    Endo T; Nemoto M; Ogawa T; Tamakai H; Hamaue N; Hirafuji M; Takeda Y; Hasegawa M; Fugii Y; Minami M
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):187-200. PubMed ID: 11913711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ipecac during the first hour after drug ingestion in human volunteers.
    Saincher A; Sitar DS; Tenenbein M
    J Toxicol Clin Toxicol; 1997; 35(6):609-15. PubMed ID: 9365428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of emetic and United State pharmacopoeia ipecac syrup in prevention of drug absorption.
    Teshima D; Suzuki A; Otsubo K; Higuchi S; Aoyama T; Shimozono Y; Saita M; Noda K
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2242-5. PubMed ID: 1980639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology of ipecac: a review.
    Manno BR; Manno JE
    Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three new O-methyltransferases are sufficient for all O-methylation reactions of ipecac alkaloid biosynthesis in root culture of Psychotria ipecacuanha.
    Nomura T; Kutchan TM
    J Biol Chem; 2010 Mar; 285(10):7722-38. PubMed ID: 20061395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
    Silber TJ
    J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons.
    Manoguerra AS; Cobaugh DJ;
    Clin Toxicol (Phila); 2005; 43(1):1-10. PubMed ID: 15732439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death due to chronic syrup of ipecac use in a patient with bulimia.
    Schiff RJ; Wurzel CL; Brunson SC; Kasloff I; Nussbaum MP; Frank SD
    Pediatrics; 1986 Sep; 78(3):412-6. PubMed ID: 2875430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of emetine and cephaeline by reversed-phase high performance liquid chromatography with fluorescence detection.
    Crouch DJ; Moran DM; Finkle BS; Peat MA
    J Anal Toxicol; 1984; 8(2):63-5. PubMed ID: 6716976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective, stability-indicating assay of the major ipecacuanha alkaloids, emetine and cephaeline, in pharmaceutical preparations by high-performance liquid chromatography using spectrofluorimetric detection.
    Elvidge DA; Johnson GW; Harrison JR
    J Chromatogr; 1989 Jan; 463(1):107-18. PubMed ID: 2715231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emetine identified in urine by HPLC, with fluorescence and ultraviolet/diode array detection, in a patient with cardiomyopathy.
    Lachman MF; Romeo R; McComb RB
    Clin Chem; 1989 Mar; 35(3):499-502. PubMed ID: 2920426
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.